Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.48 |
| ▸ | NOS1 | P29475 | 5/20 | 0.44 |
| ▸ | NOS2 | P35228 | 5/20 | 0.44 |
| ▸ | NOS3 | P29474 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | BPTF | Q12830 | 1/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | CFD | P00746 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30583565 | 1.00 | HTR6 (0.50) | HTR6PNMTENPP2LOXL2NOS1 | |
| Hydrochloric Acid SCHEMBL27831019 | 0.98 | HTR6 (0.49) | HTR6PNMTENPP2LOXL2NOS1 | |
| Hydrochloric Acid SCHEMBL31662788 | 0.98 | HTR6 (0.49) | HTR6PNMTENPP2LOXL2NOS1 | |
| SCHEMBL28000087 | 0.91 | HTR6 (0.44) | HTR6PNMTENPP2LOXL2NOS1 | |
| Hydrochloric Acid SCHEMBL28000099 | 0.86 | HTR6 (0.44) | HTR6PNMTENPP2LOXL2NOS1 | |
| SCHEMBL18905641 | 0.84 | TSHR (0.48) | HTR6CYP3A4TSHRAPP | |
| SCHEMBL20027769 | 0.83 | HTR6 (0.47) | HTR6PNMTENPP2LOXL2NOS1 | |
| SCHEMBL15511268 | 0.83 | TAAR1 (0.57) | HTR6LOXL2NOS1SMN1; SMN2 | |
| Tert-Butyl Formate SCHEMBL28788527 | 0.82 | HTR6 (0.41) | HTR6PNMTENPP2LOXL2BPTF | |
| SCHEMBL27903338 | 0.82 | HTR6 (0.53) | HTR6PNMTENPP2LOXL2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117186959-A | M45 methanol gasoline and preparation method thereof | 金玖洲新能源有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-9321756-B2 | Azole compounds as PIM inhibitors | AMGEN INC. (US) | 2016-04-26 | — | — | US | claimed |
| US-20140187553-A1 | Azole Compounds as PIM Inhibitors | AMGEM INC. (US) | 2014-07-03 | — | — | US | claimed |
| CN-103865595-A | M20 methanol gasoline power performance improver | GANSU SANGTIAN CLEANING ENERGY DEV CO LTD | 2014-06-18 | — | — | CN | claimed |
| EP-2688886-A1 | AZOLE COMPOUNDS AS PIM INHIBITORS | Amgen Inc. (US) | 2014-01-29 | — | — | EP | claimed |
| WO-2012129338-A1 | AZOLE COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2012-09-27 | — | — | WO | claimed |
| US-20260035513-A1 | RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-02-05 | — | — | US | disclosed |
| US-20250325687-A1 | CONJUGATE COMPRISING TOLL-LIKE RECEPTOR AGONIST | MABSOFT THERAPEUTICS SHANGHAI CO LTD (CN) | 2025-10-23 | — | — | US | disclosed |
| EP-4578892-A1 | RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL | Asahi Kasei Kabushiki Kaisha (JP) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025127092-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-06-19 | — | — | WO | disclosed |
| US-20250197353-A1 | METHOD OF FORMING BOND BY COUPLING REACTION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-19 | — | — | US | disclosed |
| CN-120051729-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | 日产化学株式会社 | 2025-05-27 | — | — | CN | disclosed |
| CN-119912343-A | Preparation method of N-substituent-m-aminobenzylamine | 苏州敬业医药化工有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-1278251-A | Novel carboxylic acid derivatives which carry amide side chains, prodn. of same, and use as endothelin receptor antagonists | BASF AG (DE) | 2000-12-27 | — | — | CN | disclosed |
| EP-0882715-A1 | NOVEL N-(UNSUBSTITUTED OR SUBSTITUTED)-4-SUBSTITUTED-6-(UNSUBSTITUTED OR SUBSTITUTED)PHENOXY-2-PYRIDINECARBOXAMIDES OR THIOCARBOXAMIDES, PROCESSES FOR PRODUCING THE SAME, AND HERBICIDES | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1998-12-09 | — | — | EP | disclosed |
| EP-0559310-B1 | Ink compositions | ZENECA LTD (GB) | 1996-04-03 | — | — | EP | disclosed |
| US-5383960-A | Ink jet printing inks | ZENECA LIMITED (GB) | 1995-01-24 | — | — | US | disclosed |
| EP-0372729-B1 | Reactive dyes | ZENECA LTD (GB) | 1995-01-18 | — | — | EP | disclosed |
| EP-0559310-A1 | Ink compositions | ZENECA LIMITED (GB) | 1993-09-08 | — | — | EP | disclosed |
| EP-0372729-A1 | Reactive dyes | ZENECA LIMITED (GB) | 1990-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140187553-A1 | Azole Compounds as PIM Inhibitors | PIM1, PIM3, PIM2 | HTR6 4688/4885PNMT 901/4885ENPP2 4276/4885 |
| US-20250325687-A1 | CONJUGATE COMPRISING TOLL-LIKE RECEPTOR AGONIST | TLR3, TLR7, TLR8 | HTR6 689/4885PNMT 2752/4885ENPP2 236/4885 |
| US-20260035513-A1 | RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL | TAF1, TAF1L, TAF9 | HTR6 2574/4885PNMT 3402/4885ENPP2 4280/4885 |
| US-20250197353-A1 | METHOD OF FORMING BOND BY COUPLING REACTION | CBR1, CBR3, NOX4 | HTR6 2859/4885PNMT 2890/4885ENPP2 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.